• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBloomberg

Bloomberg

Page 9 of 100
TechAlibaba shares surge to highest since 2022 on AI rally
By BloombergFebruary 13, 2025
FinanceCommonwealth Bank of Australia CEO sees weak private sector
By Harry Brumpton and BloombergFebruary 11, 2025
FinanceHong Kong’s latest bubble tea IPO mints another billionaire
By Filipe Pacheco, Diana Li and BloombergFebruary 11, 2025
TechCATL files for Hong Kong listing that could raise $5 billion
By Foster Wong and BloombergFebruary 11, 2025
TechPhilippine lawmakers plan to approve bill to ban ore exports
By Cliff Venzon, Neil Jerome Morales and BloombergFebruary 6, 2025
FinanceNew Zealand hints at letting more foreign investors buy homes
By Tracy Withers and BloombergFebruary 6, 2025
TechChina’s 60-second dramas head to the U.S. after beating box office
By Sohee Kim and BloombergFebruary 5, 2025
FinanceHonda-Nissan deal thrown into doubt only weeks after talks began
By Nicholas Takahashi and BloombergFebruary 5, 2025
PoliticsThailand cuts power supply to Myanmar in blow to scam centers
By Patpicha Tanakasempipat and BloombergFebruary 5, 2025
PoliticsTrump plans to speak with Xi as deadline for China tariffs looms
By Jasmine Ng and BloombergFebruary 3, 2025
LifestyleChinese tourists avoid far-flung trips over lunar holiday
By BloombergJanuary 23, 2025
TechSK Hynix’s stock dips after profit misses lofty expectations
By Yoolim Lee and BloombergJanuary 22, 2025
PoliticsIndia set to take back 18,000 citizens from U.S. to placate Trump
By Sudhi Ranjan Sen, Dan Strumpf and BloombergJanuary 21, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
HealthHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
PoliticsPanama opens audit of Chinese port operator while Trump threatens to take canal back
By Michael McDonald, Shirley Zhao and BloombergJanuary 20, 2025
1...
  • 7
  • 8
  • 9
  • 10
  • 11
...100
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
Success
Walmart exec says U.S. workforces needs to take inspiration from China where ‘5 year-olds are learning DeepSeek’An image of a popular article
By Preston ForeFebruary 27, 2026
Personal Finance
Current price of gold as of February 27, 2026An image of a popular article
By Danny BakstFebruary 27, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.